Effects of FSTL1 on cell proliferation in breast cancer cell line MDA ‑MB‑231 and its brain metastatic variant MDA‑MB‑231‑BR.

This study identified FSTL1 as an inhibitor of cell proliferation in MDA‑MB‑231 and 231‑BR cell lines, which may provide new insights into the development and management of breast cancer. PMID: 29048681 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29048681?dopt=Abstract

Source: Oncology Reports - October 20, 2017 Category: Cancer & Oncology Tags: Oncol Rep Source Type: research